Commercial Physical & Biological Research Stocks

12 commercial physical & biological research stocks with fundamental analysis, valuation charts, and SEC filing data. Industry median P/E is 28.9, median ROIC 0.0%, and combined market cap of $104.1B.

IQV — IQVIA HOLDINGS INC.

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence powered by proprietary data assets, advanced analytics, and healthcare-grade AI.

INCY — INCYTE CORP

Incyte is a global biopharmaceutical company engaged in the discovery, development, and commercialization of proprietary therapeutics across three therapeutic areas: Hematology, Oncology, and Inflamma.

MEDP — Medpace Holdings, Inc.

Medpace is one of the world's leading clinical contract research organizations (CROs) by revenue, providing full-service Phase I-IV clinical development services exclusively to biotechnology, pharmace.

ICLR — ICON PLC

CRL — CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Charles River Laboratories is a leading, full-service non-clinical global drug development partner operating through three reportable segments: Research Models and Services (RMS), Discovery and Safety.

ABSI — Absci Corp

NRC — NATIONAL RESEARCH CORP

OABI — OmniAb, Inc.

MXCT — MAXCYTE, INC.

BUDZ — WEED, INC.

CBIH — Cannabis Bioscience International Holdings, Inc.

NOTV — Inotiv, Inc.